SAN DIEGO, CA—Biologic therapies used to treat psoriasis show potential for decreasing both the volume and the burden of inflammation in atherosclerotic plaques, providing extra ammunition to combat ...

Which patients with a history of myocardial infarction (MI) are at risk of having another? The tools to predict risk for recurrent cardiac events in patients with established coronary artery disease ...

The LoDoCo2 trial found a reduced cardiovascular risk with low-dose colchicine in patients with chronic coronary disease. In this substudy, attenuation of pericoronary adipose tissue did not differ ...

Please provide your email address to receive an email when new articles are posted on . Risk for major adverse cardiovascular events emerged earlier with less plaque development in women compared with ...

For many years, 2 axioms have ruled our thoughts and discussions of coronary atherosclerosis. The first axiom was that patients were at risk for acute coronary syndromes (ACS) if their coronary ...

Please provide your email address to receive an email when new articles are posted on . The virus that causes COVID-19 may expedite progression of coronary lesions to high-risk plaque. SARS-CoV-2 was ...

OAK BROOK, Ill. - People living with human immunodeficiency virus (HIV) and without known cardiovascular disease have two to three times the noncalcified coronary plaque burden of non-HIV healthy ...

Almost half of asymptomatic people have atherosclerotic plaque on coronary CT angiography (CCTA)—including a not inconsequential number with zero coronary artery calcium (CAC)—but only a small ...